“endo-pharmaceuticals” Archives

Entry Author Date Location
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Trevi Therapeutics Files for IPO to Fund Anti-Itching Drug R&D 04/08/19 New York
How Pozen’s Tribute Pharma Deal Paves New Path for “Safer Aspirin” 06/16/15 Raleigh Durham
Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More 04/06/15 Raleigh Durham
Valeant Boosts Bid For Salix By $1B, Endo Withdraws 03/16/15 Raleigh Durham
Salix Bidding War Erupts as Endo Tops Valeant’s Offer 03/11/15 Raleigh Durham
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
NYC’s Coronado Biosciences Plans Two Drug Trials, Wall Street Debut, and Boston Move 07/21/11 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Botox’s Singh Moves on to San Diego’s Transdel, Developer of Pain Reliever to Rival Advil 09/28/09 San Diego
Boston-Area Tech Layoffs Slow: A Recap of Summer’s Job Cuts at Analog Devices, CombinatoRx, and Other Firms 08/17/09 Boston
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News 06/17/09 Boston
New Owner Laying Off a Quarter of Indevus Pharma Employees 06/10/09 Boston
Lankau New CEO at Logical 05/11/09 Boston
Archemix Partners with GSK, EMC Acquires SourceLabs Assets, Satori Raises $22M to Take on Alzheimer’s, & More Boston-Area Deals News 01/09/09 Boston
Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News 01/07/09 Boston
Indevus, Maker of ‘Male Menopause’ Drug, Agrees to $370M Takeover by Endo 01/05/09 Boston
Page 1 of 1